SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000950142-12-000405
Filing Date
2012-02-15
Accepted
2012-02-15 17:19:54
Documents
3
Group Members
AISLING CAPITAL II LPAISLING CAPITAL PARTNERS LLCAISLING CAPITAL PARTNERS LPANDREW SCHIFFDENNIS PURCELLSTEVE ELMS

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D eh1200309_13d-cempra.htm SC 13D 242719
2 EXHIBIT 1 eh1200309_ex1.htm EX-99.1 28803
3 EXHIBIT 2 eh1200309_ex2.htm EX-99.2 22191
  Complete submission text file 0000950142-12-000405.txt   295415
Mailing Address 88 SEVENTH AVE 30TH FL NEW YORK NY 10106
Business Address 88 SEVENTH AVE 30TH FL NEW YORK NY 10106
Aisling Capital II LP (Filed by) CIK: 0001350778 (see all company filings)

IRS No.: 000000000
Type: SC 13D

Mailing Address 6340 QUADRANGLE DRIVE SUITE 100 CHAPEL HILL NC 27517-8149
Business Address 6340 QUADRANGLE DRIVE SUITE 100 CHAPEL HILL NC 27517-8149 919-313-6617
CEMPRA, INC. (Subject) CIK: 0001461993 (see all company filings)

IRS No.: 262644445 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-86624 | Film No.: 12616844
SIC: 2834 Pharmaceutical Preparations